AFAR News

AFAR board members, grantees, and award winners regularly publish research in leading academic journals and frequently lend their insights to popular media. AFAR is pleased to share updates on their work.

AFAR in the News: SuperAgers Initiative featured in Nature Aging, written by PI Sofiya Milman, MD, MS
AFAR in the News: SuperAgers Initiative featured in Nature Aging, written by PI Sofiya Milman, MD, MS
AFAR Experts in the News: Austad and Barzilai in Fortune Well on metformin and the TAME Trial
AFAR Experts in the News: Austad and Barzilai in Fortune Well on metformin and the TAME Trial
AFAR Experts in the News: Barzilai and Sinclair on premier episode of NPR podcast, "Seeking a Scientist"
AFAR Experts in the News: Barzilai and Sinclair on premier episode of NPR podcast, "Seeking a Scientist"
AFAR Experts in the News: Austad, Barzilai, and Pearls on Centenarians, Immune Health, and Healthspan in HealthDay
AFAR Experts in the News: Austad, Barzilai, and Pearls on Centenarians, Immune Health, and Healthspan in HealthDay
Announcing the inaugural Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience recipients
Announcing the inaugural Hevolution/AFAR New Investigator Awards in Aging Biology and Geroscience recipients
AFAR responds to Wall Street Journal article on on Metformin and extending healthspan
AFAR responds to Wall Street Journal article on on Metformin and extending healthspan
AFAR in the News: Stephanie Lederman and AFAR featured in Inside Philanthropy whitepaper on giving for neuroscience
AFAR in the News: Stephanie Lederman and AFAR featured in Inside Philanthropy whitepaper on giving for neuroscience
Board Member in the News: Steve Austad authors tribute to the late George M. Martin in GeroSciecne
Board Member in the News: Steve Austad authors tribute to the late George M. Martin in GeroSciecne
Board Members in the News: Nir Barzilai and David Sinclair on how biological age can be targeted in Fortune
Board Members in the News: Nir Barzilai and David Sinclair on how biological age can be targeted in Fortune